Wholesale Price China 4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride - 2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Trelagliptin Succinate Intermediate High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
Wholesale Price China 4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride - 2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Trelagliptin Succinate Intermediate High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Trelagliptin Succinate (CAS: 1029877-94-8) Related Intermediates:
6-Chloro-3-methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-Cyano-5-Flurobenzyl Bromide CAS: 421552-12-7

Chemical Name 2-Cyano-5-Flurobenzyl Bromide
Synonyms 2-(Bromomethyl)-4-Fluorobenzonitrile
CAS Number 421552-12-7
CAT Number RF-PI143
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C8H5BrFN
Molecular Weight 214.03
Melting Point 67.0 to 71.0℃
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-Yellow Powder 
Purity / Analysis Method ≥98.0% (HPLC) 
Moisture (K.F) ≤0.50%
Test Standard Enterprise Standard
Usage Trelagliptin Succinate (CAS: 1029877-94-8) Intermediate; Organic Synthesis

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis.

2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7)  can be used in the synthesis of Trelagliptin Succinate (CAS: 1029877-94-8). 

Trelagliptin Succinate (CAS: 1029877-94-8) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor. An antidiabetic agent. Orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. Trelagliptin Succinate has a long duration of action and is well tolerated in clinical studies. Trelagliptin (as the salt Trelagliptin succinate) was approved for use in Japan in March 2015. Takeda, the company that developed Trelagliptin, chose to not get approval for the drug in the USA and EU. 


Product detail pictures:

Wholesale Price China 4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride - 2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Trelagliptin Succinate Intermediate  High Purity – Ruifu detail pictures


Related Product Guide:

Wholesale Price China 4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride - 2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Trelagliptin Succinate Intermediate High Purity – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us